SolarEdge (SEDG) 10-Q 6 Nov 15 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2015	Oct. 28, 2015
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1
Entity Registrant Name	SolarEdge Technologies Inc
Entity Central Index Key	1,419,612
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		39,304,342

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 146,729	$ 144,750
Restricted cash	3,588	3,639
Trade receivables, net	47,366	35,428
Prepaid expenses and other accounts receivable	20,733	32,645
Inventories	79,907	73,950
Total current assets	298,323	290,412
PROPERTY AND EQUIPMENT, NET	17,272	14,717
LONG-TERM LEASE DEPOSIT AND PREPAID EXPENSES	601	$ 529
INTANGIBLE ASSETS, NET	779
Total assets	316,975	$ 305,658
CURRENT LIABILITIES:
Trade payables	67,180	80,684
Employees and payroll accruals	7,898	6,814
Warranty obligations	10,587	9,431
Deferred revenues	2,175	1,676
Accrued expenses and other accounts payable	8,459	6,987
Total current liabilities	96,299	105,592
LONG-TERM LIABILITIES
Warranty obligations	25,317	22,448
Deferred revenues	9,760	8,289
Lease incentive obligation	2,374	2,385
Total long-term liabilities	$ 37,451	$ 33,122
COMMITMENTS AND CONTINGENT LIABILITIES
Share capital
Common stock of $0.0001 par value - Authorized: 125,000,000 shares as of September 30, 2015 (unaudited) and June 30, 2015; issued and outstanding: 39,303,892 and 39,297,539 shares as of September 30, 2015 (unaudited) and June 30, 2015, respectively.	$ 4	$ 4
Additional paid-in capital	289,004	287,152
Accumulated other comprehensive loss	(225)	(222)
Accumulated deficit	(105,558)	(119,990)
Total stockholders' equity	183,225	166,944
Total liabilities and stockholders' equity	$ 316,975	$ 305,658

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2015	Jun. 30, 2015
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, authorized shares	125,000,000	125,000,000
Common stock, issued shares	39,303,892	39,297,539
Common stock, outstanding shares	39,303,892	39,297,539

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenues	$ 115,054	$ 66,969
Cost of revenues	81,527	52,939
Gross profit	33,527	14,030
Operating expenses:
Research and development, net	6,991	5,059
Sales and marketing	8,244	5,461
General and administrative	3,418	1,159
Total operating expenses	18,653	11,679
Operating income	14,874	2,351
Financial income (expenses), net	(72)	516
Income before taxes on income	14,802	2,867
Taxes on income	370	347
Net income	$ 14,432	$ 2,520
Net basic earnings per share of common stock	$ 0.37
Net diluted earnings per share of common stock	$ 0.32
Weighted average number of shares used in computing net basic earnings per share of common stock	39,301,620	2,812,684
Weighted average number of shares used in computing net diluted earnings per share of common stock	44,455,964	2,812,684

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME [Abstract]
Net income	$ 14,432	$ 2,520
Cash flow hedges:
Changes in unrealized gains (losses)	37
Reclassification adjustments for losses included in net income	1
Net change	38
Foreign currency translation adjustments, net	(41)	$ (125)
Other comprehensive loss	(3)	(125)
Comprehensive income	$ 14,429	$ 2,395

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows provided by (used in) operating activities:
Net income	$ 14,432	$ 2,520
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	738	$ 542
Amortization of intangible assets	21
Stock-based compensation related to employee and non-employee consultants stock options	1,832	$ 320
Realized losses on Cash Flow Hedges	$ 1
Interest expenses related to Bank Loan		$ 24
Financial income, net related to term loan		(491)
Remeasurement of warrants to purchase preferred and common stock		(15)
Changes in assets and liabilities:
Inventories	$ (5,956)	(4,311)
Prepaid expenses and other accounts receivable	11,811	(5,527)
Trade receivables, net	(11,928)	(7,565)
Trade payables	(13,500)	9,871
Employees and payroll accruals	1,044	390
Warranty obligations	4,025	3,101
Deferred revenues	1,970	864
Accrued expenses and other accounts payable	1,467	$ 19
Lease incentive obligation	(11)
Net cash provided by (used in) operating activities	5,946	$ (258)
Cash flows used in investing activities:
Purchase of property and equipment	(3,292)	$ (1,002)
Purchase of intangible assets	(800)
Decrease in restricted cash	51	$ 13
Decrease in short and long-term lease deposits	73	29
Net cash used in investing activities	$ (3,968)	(960)
Cash flows from financing activities:
Proceeds from short-term bank loans		6,000
Payments of term loan		(798)
Proceeds from issuance of Convertible Preferred stock, net		20,998
Proceeds from exercise of employee stock options	$ 17	8
Net cash provided by financing activities	17	26,208
Increase in cash and cash equivalents	1,995	24,990
Cash and cash equivalents at the beginning of the period	144,750	9,754
Erosion due to exchange rate differences	(16)	(2)
Cash and cash equivalents at the end of the period	$ 146,729	34,742
Supplemental disclosure of non-cash financing activities:
Deferred issuance costs		508
Issuance expenses not paid in cash		523
Issuance of Series E Convertible Preferred stock in consideration of receivables on account of stock		$ 2,000
Exercise of employee stock options not paid in cash	$ 3
Unrealized gains on cash flow hedges	$ 37

GENERAL

GENERAL	3 Months Ended
	Sep. 30, 2015
GENERAL [Abstract]
GENERAL	NOTE 1:- GENERAL a. SolarEdge Technologies Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution that maximizes power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company's products consist mainly of (i) power optimizers which maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) and (iii) a related cloud based monitoring platform, that collects and processes information from the power optimizers and inverters of a solar PV system to enable customers and system owners, as applicable, to monitor and manage the solar PV systems. The Company operates its business itself and through its wholly-owned subsidiaries: SolarEdge Technologies Ltd. in Israel; SolarEdge Technologies GmbH in Germany; SolarEdge Technologies (China) Co., Ltd in China; SolarEdge Technologies (Australia) PTY Ltd. in Australia; SolarEdge Technologies (Canada) Ltd. in Canada; SolarEdge Technologies (Holland) B.V. in the Netherlands; SolarEdge Technologies (UK) Ltd in United Kingdom; SolarEdge Technologies (Japan) Co., Ltd. in Japan and SolarEdge Technologies (France) SARL in France (collectively, the “subsidiaries”). Except for SolarEdge Technologies Ltd in Israel, which carries out the research and development, management of manufacturing, global sales and support and management activities, the other subsidiaries are engaged solely in selling, marketing and support activities. The Company was incorporated in Delaware in August 2006 and began commercial sale of its products in January 2010. b. Recent accounting pronouncements: Inventory: On July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330), Simplifying the Measurement of Inventory, which changes the measurement principle for inventory from the lower of cost or market to lower of cost and net realizable value. Net realizable value is defined as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.” ASU 2015-11 eliminates the guidance that entities consider replacement cost or net realizable value less an approximately normal profit margin in the subsequent measurement of inventory when cost is determined on a first-in, first-out or average cost basis. The provisions of ASU 2015-11 are effective for public entities with fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted. The Company is in the process of evaluating the impact to its consolidated financial position, consolidated results of operations, and consolidated cash flows of the adoption of ASU 2015-11. c. The significant accounting policies applied in the Company's audited annual consolidated financial statements as of June 30, 2015 are applied consistently in these financial statements. d. Basis of Presentation: The accompanying unaudited consolidated interim financial statements have been prepared in accordance with Article 10 of Regulation S-X, “Interim Financial Statements” and the rules and regulations for Form 10-Q of the Securities and Exchange Commission (the “SEC”). Pursuant to those rules and regulations, the Company has condensed or omitted certain information and footnote disclosure it normally includes in its annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). e. The Company depends on two Two 71 79 f. Derivative financial instruments: The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. In addition to the above mentioned cash flow hedges transactions, the Company also entered into derivative instrument arrangements to hedge the Company's exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flows hedges, as defined by ASC 815, and therefore all gains and losses, resulted from fair value remeasurements, were recorded immediately in the statement of operations, as financial expenses, net. 23,217 6 342 41 301 1 Fair Value of Derivative Instruments Balance Sheet Location As of September 30, 2015 (unaudited) As of June 30, 2015 Derivative Assets Foreign exchange forward contracts Other accounts receivable and prepaid expenses (*) 301 859 Total 301 859 (*) Estimated to be reclassified into earnings during 2016. The effect of derivative instruments in cash flow hedging transactions on income and other comprehensive income (“OCI”) for the three months ended September 30, 2015 and 2014 is summarized below: Gains on Derivatives Recognized in OCI for the three months ended September 30, 2015 2014 (unaudited) Foreign exchange forward contracts 37 - Gains (Losses) Reclassified from OCI into Income for the three months ended September 30, 2015 2014 (unaudited) Foreign exchange forward contracts (1) - g. On March 9, 2015, the Company and Beacon Power LLC, a Delaware limited liability company (“Beacon”) entered into a patent purchase agreement under which the Company agreed to purchase all rights in the patents. In July 2015 the Company completed the purchase of the patents for $ 800 The patents are stated at cost, net of accumulated amortization. Amortization is calculated by the straight-line method over 10 Amortization expenses for the three months ended September 30, 2015 (unaudited) were $ 21 _ h. Accumulated other comprehensive loss: The following table summarizes the changes in accumulated balances of other comprehensive loss for the three months ended September 30, 2015 (unaudited): Unrealized gains (losses) on cash flow hedges Unrealized gains (losses) on foreign currency translation Total Beginning balance $ - $ (222) $ (222) Other comprehensive income (loss) before reclassifications 37 (41) (4) Losses reclassified from accumulated other comprehensive income (loss) 1 - 1 Net current period other comprehensive income (loss) 38 (41) (3) Ending balance $ 38 $ (263) $ (225)

INVENTORIES

INVENTORIES	3 Months Ended
	Sep. 30, 2015
INVENTORIES [Abstract]
INVENTORIES	NOTE 2:- INVENTORIES September 30, 2015 June 30, 2015 Unaudited Raw materials $ 16,870 $ 14,405 Finished goods 63,037 59,545 $ 79,907 $ 73,950

WARRANTY OBLIGATIONS

WARRANTY OBLIGATIONS	3 Months Ended
	Sep. 30, 2015
WARRANTY OBLIGATIONS [Abstract]
WARRANTY OBLIGATIONS	NOTE 3:- WARRANTY OBLIGATIONS Changes in the Company's product warranty liability for the three months ended September 30, 2015 and 2014 were as follows: Three months ended September 30, 2015 2014 (unaudited) Balance, at beginning of period $ 31,879 $ 18,181 Additions and adjustments to cost of revenues 6,295 4,244 Usage and current warranty expenses (2,270 ) (1,143 ) Balance, at end of period 35,904 21,282 Less current portion (10,587 ) (6,063 ) Long term portion $ 25,317 $ 15,219

REVOLVING CREDIT LINE

REVOLVING CREDIT LINE	3 Months Ended
	Sep. 30, 2015
REVOLVING CREDIT LINE [Abstract]
REVOLVING CREDIT LINE	NOTE 4:- REVOLVING CREDIT LINE In June 2011, the Company entered into an agreement for a revolving line of credit from a Bank Lender (the "Bank Lender"). February 17, 2015, the Company amended and restated the agreement with the Bank Lender for a revolving line of credit, which permits aggregate borrowings of up to $ 40 80 Bank Lender's prime rate 0.5 2.0 December 31, 2016 In connection with the amended and restated revolving line of credit, the Company granted the Bank Lender security interests in substantially all of the Company's assets, including a first priority security interest in the Company's trade receivables, cash and cash equivalents. Financial covenants contained in the agreement require the Company to maintain EBITDA and liquidity at specified levels. 6,750

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Sep. 30, 2015
FAIR VALUE MEASUREMENTS [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 5:- FAIR VALUE MEASUREMENTS The Company evaluates assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level to classify them for each reporting period. There have been no transfers between fair value measurements levels during the three months ended September 30, 2015. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: Level 1- Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2- Include other inputs that are directly or indirectly observable in the marketplace. Level 3- Unobservable inputs which are supported by little or no market activity. The following table sets forth the Company's assets that were measured at fair value as of September 30, 2015 (unaudited) by level within the fair value hierarchy: Balance as of Fair value measurements Description September 30, 2015 (unaudited) Level 1 Level 2 Level 3 Derivative instruments asset $ 301 - $ 301 - The following table sets forth the Company's assets that were measured at fair value as of June 30, 2015 by level within the fair value hierarchy: Balance as of Fair value measurements Description June 30, 2015 Level 1 Level 2 Level 3 Derivative instruments asset $ 859 - $ 859 -

LEASE INCENTIVE OBLIGATION

LEASE INCENTIVE OBLIGATION	3 Months Ended
	Sep. 30, 2015
LEASE INCENTIVE OBLIGATION[Abstract]
LEASE INCENTIVE OBLIGATION	NOTE 6:- LEASE INCENTIVE OBLIGATION The Company has an operating lease agreement for a building in Herzilia, Israel. In connection with this lease, the Company and its third party lessor (the "Lessor"), agreed that the Lessor would pay approximately $ 2,937 2,875

COMMITMENTS AND CONTINGENT LIAB

COMMITMENTS AND CONTINGENT LIABILITIES	3 Months Ended
	Sep. 30, 2015
COMMITMENTS AND CONTINGENT LIABILITIES [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	NOTE 7:- COMMITMENTS AND CONTINGENT LIABILITIES a. Lease commitments: The Company and its subsidiaries lease their operating facilities under non-cancelable operating lease agreements, which expire over the next ten Year ended June 30, (unaudited) 2016 1,692 2017 2,122 2018 2,041 2019 1,906 2020 and thereafter 8,319 16,080 Rent expenses for the three months ended September 30, 2015 (unaudited) and 2014 (unaudited) were approximately $ 535 315 b. Guarantees: As of September 30, 2015 (unaudited), contingent liabilities exist regarding guarantees in the amount of $ 780 51 82 c. Royalty and Governmental commitments: As of September 30, 2015 (unaudited), the aggregate contingent liability to the Binational Industrial Research and Development Foundation (BIRD F) amounted to approximately $ 1,131 743 d. Contractual purchase obligations: The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories held by contract manufacturers and purchase orders initiated by the contract manufacturers and suppliers, which cannot be canceled without penalty. The Company utilizes third parties to manufacture its products. In addition, it acquires raw materials or other goods and services, including product components, by issuing to suppliers authorizations to purchase based on its projected demand and manufacturing needs. As of September 30, 2015 (unaudited), the Company had non-cancelable purchase obligations totaling approximately $ 72,781 1,552 e. Legal claims: From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.

STOCK CAPITAL

STOCK CAPITAL	3 Months Ended
	Sep. 30, 2015
STOCK CAPITAL [Abstract]
STOCK CAPITAL	NOTE 8:- STOCK CAPITAL a. On March 23, 2015, the Company's board of directors and the requisite holders of the Company's capital stock consented to a 1-for- 3 b. Common Stock: Authorized Issued and outstanding Number of shares September 30, 2015 June 30, 2015 September 30, 2015 June 30, 2015 (unaudited) (unaudited) Stock of $ 0.0001 Common stock 125,000,000 125,000,000 39,303,892 39,297,539 c. Stock Incentive plans: The Company's 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. On March 31, 2015, once the Company completed its Initial Public Offering (“IPO”), the 2007 Plan has been terminated and no further awards will be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, RSUs and other share-based awards to directors, employees, officers and consultants of the Company and its Subsidiaries. As of September 30, 2015 (unaudited), a total of 1,822,484 5 5 . The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is ten million ( 10,000,000 As of September 30, 2015 (unaudited), an aggregate of 876,020 A summary of the activity in the share options and RSUs granted to employees and members of the board of directors for the three months ended September 30, 2015 (unaudited) and related information follows: Weighted average Weighted remaining Number average contractual Aggregate of exercise term intrinsic Options/RSUs price in years Value Outstanding as of July 1, 2015 6,102,222 $ 3.10 7.08 $ 202,889 Options granted 228,800 $ 25.09 RSUs granted 630,056 - Exercised (3,923 ) $ 2.62 Forfeited or expired (15,844 ) $ 2.35 Outstanding as of September 30, 2015 6,941,311 $ 3.55 7.21 $ 134,964 Vested and expected to vest as of September 30, 2015 6,582,179 $ 3.51 7.10 $ 128,191 Exercisable as of September 30, 2015 3,793,798 $ 2.28 5.63 $ 78,326 The aggregate intrinsic value represents the total intrinsic value (the difference between the fair value of the Company's common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option and RSU holders had all option and RSU holders exercised their options and RSU on the last day of each period. The total intrinsic value of options exercised during the three months ended on September 30, 2015 (unaudited) was $ 107 25.09 The options and RSUs outstanding as of September 30, 2015 (unaudited) have been separated into exercise price ranges as follows: Weighted Options Weighted Outstanding average exercisable average Range of as of remaining as of remaining exercise September 30, contractual September 30, contractual price 2015 Life in years 2015 Life in years $ 0.00 689,497 9.86 - - $ 0.50 1.50 1,244,156 3.43 1,244,156 3.43 $ 1.68 2.46 2,089,547 6.04 1,896,126 5.99 $ 3.03 3.96 661,501 8.29 291,659 8.24 $ 5.01 5.04 1,994,482 9.17 361,857 9.15 $ 9.36 33,328 9.34 - - $ 25.09 228,800 9.89 - - 6,941,311 7.21 3,793,798 5.63 d. Options and RSUs issued to non-employee consultants: The Company has granted options and RSUs to purchase common shares to non-employee consultants as of September 30, 2015 (unaudited) as follows: Outstanding Exercisable as of as of Issuance September 30, Exercise September 30, Exercisable Date 2015 price 2015 Through July 31, 2008 33,333 0.87 33,333 July 31, 2018 January 26, 2011 5,000 2.01 5,000 January 26, 2021 January 26, 2012 33,333 2.46 33,333 January 26, 2022 October 24, 2012 6,666 2.46 5,000 October 24, 2022 January 23, 2013 3,333 3.03 2,361 January 23, 2023 January 27, 2014 4,998 3.51 1,943 January 27, 2024 May 1, 2014 6,000 3.51 2,417 May 1, 2024 September 17, 2014 10,830 3.96 3,436 September 17, 2024 October 29, 2014 6,668 5.01 1,222 October 29, 2024 August 19, 2015 28,167 0.00 - 138,328 88,045 In connection with the grant of stock options and RSUs to non-employee consultants, the Company recorded stock compensation expenses in the three months ended September 30, 2015 (unaudited) and 2014 (unaudited) in the amounts $ 119 23 Stock-based compensation expense for employees and consultants: The Company recognized stock-based compensation expenses related to stock options and RSUs granted to employees and non-employees in the consolidated statement of operations for the three months ended on September 30, 2015 (unaudited) and 2014 (unaudited), as follows: Three months ended September 30, 2015 Three months ended September 30, 2014 Cost of revenues $ 180 $ 37 Research and development 395 110 Selling and marketing 616 102 General and administrative 641 71 Total stock-based compensation expense $ 1,832 $ 320 As of September 30, 2015 (unaudited) there was a total unrecognized compensation expense of $ 27,866

BASIC AND DILUTED NET EARNINGS

BASIC AND DILUTED NET EARNINGS PER SHARE	3 Months Ended
	Sep. 30, 2015
BASIC AND DILUTED NET EARNINGS PER SHARE [Abstract]
BASIC AND DILUTED NET EARNINGS PER SHARE	NOTE 9:- BASIC AND DILUTED NET EARNINGS PER SHARE 0 1,552,809 Basic and diluted earnings per share is presented in conformity with the two-class method for participating securities for the periods prior to their conversion. Under this method the earnings per share for each class of shares are calculated assuming 100% of the Company's earnings are distributed as dividends to each class of shares based on their contractual rights. Three months ended September 30, 2015 2014 (unaudited) Numerator: Net income 14,432 2,520 Dividends accumulated for the period - (2,520 ) Net income available to shareholders of common stock 14,432 - Denominator: Shares used in computing net earnings per share of common stock, basic 39,301,620 2,812,684 Numerator: Net income 14,432 2,520 Dividends accumulated for the period - (2,520 ) Net income available to shareholders of common stock 14,432 - Denominator: Shares used in computing net earnings per share of common stock, diluted 44,455,964 2,812,684

CONCENTRATION OF CREDIT RISK AN

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS	3 Months Ended
	Sep. 30, 2015
CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS [Abstract]
CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS	NOTE 10:- CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS a. b. For the three month period ended September 30, 2015 (unaudited), the Company had two major customers that accounted for approximately 25.8 24.6 As of September 30, 2015 (unaudited), three customers accounted for 49.5 30.0

GENERAL (Tables)

GENERAL (Tables)	3 Months Ended
	Sep. 30, 2015
GENERAL [Abstract]
Schedule of Fair Value of Derivative Instruments	Fair Value of Derivative Instruments Balance Sheet Location As of September 30, 2015 (unaudited) As of June 30, 2015 Derivative Assets Foreign exchange forward contracts Other accounts receivable and prepaid expenses (*) 301 859 Total 301 859
Schedule of Derivative Instruments Gains Recognized in OCI	Gains on Derivatives Recognized in OCI for the three months ended September 30, 2015 2014 (unaudited) Foreign exchange forward contracts 37 -
Schedule of Derivative Gains (Losses) Reclassified From OCI Into Income	Gains (Losses) Reclassified from OCI into Income for the three months ended September 30, 2015 2014 (unaudited) Foreign exchange forward contracts (1) -
Changes in Accumulated Balance of Other Comprehensive Loss	Unrealized gains (losses) on cash flow hedges Unrealized gains (losses) on foreign currency translation Total Beginning balance $ - $ (222) $ (222) Other comprehensive income (loss) before reclassifications 37 (41) (4) Losses reclassified from accumulated other comprehensive income (loss) 1 - 1 Net current period other comprehensive income (loss) 38 (41) (3) Ending balance $ 38 $ (263) $ (225)

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Sep. 30, 2015
INVENTORIES [Abstract]
Schedule of inventories	September 30, 2015 June 30, 2015 Unaudited Raw materials $ 16,870 $ 14,405 Finished goods 63,037 59,545 $ 79,907 $ 73,950

WARRANTY OBLIGATIONS (Tables)

WARRANTY OBLIGATIONS (Tables)	3 Months Ended
	Sep. 30, 2015
WARRANTY OBLIGATIONS [Abstract]
Schedule of warranty obligations	Three months ended September 30, 2015 2014 (unaudited) Balance, at beginning of period $ 31,879 $ 18,181 Additions and adjustments to cost of revenues 6,295 4,244 Usage and current warranty expenses (2,270 ) (1,143 ) Balance, at end of period 35,904 21,282 Less current portion (10,587 ) (6,063 ) Long term portion $ 25,317 $ 15,219

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Sep. 30, 2015
FAIR VALUE MEASUREMENTS [Abstract]
Schedule of assets and liabilities measured at fair value by level	Balance as of Fair value measurements Description September 30, 2015 (unaudited) Level 1 Level 2 Level 3 Derivative instruments asset $ 301 - $ 301 - Balance as of Fair value measurements Description June 30, 2015 Level 1 Level 2 Level 3 Derivative instruments asset $ 859 - $ 859 -

COMMITMENTS AND CONTINGENT LI21

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	3 Months Ended
	Sep. 30, 2015
COMMITMENTS AND CONTINGENT LIABILITIES [Abstract]
Schedule of future minimum lease commitments	Year ended June 30, (unaudited) 2016 1,692 2017 2,122 2018 2,041 2019 1,906 2020 and thereafter 8,319 16,080

STOCK CAPITAL (Tables)

STOCK CAPITAL (Tables)	3 Months Ended
	Sep. 30, 2015
STOCK CAPITAL [Abstract]
Schedule of composition of common stock capital	Authorized Issued and outstanding Number of shares September 30, 2015 June 30, 2015 September 30, 2015 June 30, 2015 (unaudited) (unaudited) Stock of $ 0.0001 Common stock 125,000,000 125,000,000 39,303,892 39,297,539
Option [Member]
STOCK CAPITAL
Schedule of recognized stock-based compensation expenses	Three months ended September 30, 2015 Three months ended September 30, 2014 Cost of revenues $ 180 $ 37 Research and development 395 110 Selling and marketing 616 102 General and administrative 641 71 Total stock-based compensation expense $ 1,832 $ 320
Option [Member] | Employees and members of the board of directors [Member]
STOCK CAPITAL
Summary of the activity in the share options	Weighted average Weighted remaining Number average contractual Aggregate of exercise term intrinsic Options/RSUs price in years Value Outstanding as of July 1, 2015 6,102,222 $ 3.10 7.08 $ 202,889 Options granted 228,800 $ 25.09 RSUs granted 630,056 - Exercised (3,923 ) $ 2.62 Forfeited or expired (15,844 ) $ 2.35 Outstanding as of September 30, 2015 6,941,311 $ 3.55 7.21 $ 134,964 Vested and expected to vest as of September 30, 2015 6,582,179 $ 3.51 7.10 $ 128,191 Exercisable as of September 30, 2015 3,793,798 $ 2.28 5.63 $ 78,326
Schedule of exercise price range of options	Weighted Options Weighted Outstanding average exercisable average Range of as of remaining as of remaining exercise September 30, contractual September 30, contractual price 2015 Life in years 2015 Life in years $ 0.00 689,497 9.86 - - $ 0.50 1.50 1,244,156 3.43 1,244,156 3.43 $ 1.68 2.46 2,089,547 6.04 1,896,126 5.99 $ 3.03 3.96 661,501 8.29 291,659 8.24 $ 5.01 5.04 1,994,482 9.17 361,857 9.15 $ 9.36 33,328 9.34 - - $ 25.09 228,800 9.89 - - 6,941,311 7.21 3,793,798 5.63
Option [Member] | Non-employee consultants
STOCK CAPITAL
Summary of the activity in the share options	Outstanding Exercisable as of as of Issuance September 30, Exercise September 30, Exercisable Date 2015 price 2015 Through July 31, 2008 33,333 0.87 33,333 July 31, 2018 January 26, 2011 5,000 2.01 5,000 January 26, 2021 January 26, 2012 33,333 2.46 33,333 January 26, 2022 October 24, 2012 6,666 2.46 5,000 October 24, 2022 January 23, 2013 3,333 3.03 2,361 January 23, 2023 January 27, 2014 4,998 3.51 1,943 January 27, 2024 May 1, 2014 6,000 3.51 2,417 May 1, 2024 September 17, 2014 10,830 3.96 3,436 September 17, 2024 October 29, 2014 6,668 5.01 1,222 October 29, 2024 August 19, 2015 28,167 0.00 - 138,328 88,045

BASIC AND DILUTED NET EARNING23

BASIC AND DILUTED NET EARNINGS PER SHARE (Tables)	3 Months Ended
	Sep. 30, 2015
BASIC AND DILUTED NET EARNINGS PER SHARE [Abstract]
Schedule of computation of basic and diluted net earnings (loss) per share	Three months ended September 30, 2015 2014 (unaudited) Numerator: Net income 14,432 2,520 Dividends accumulated for the period - (2,520 ) Net income available to shareholders of common stock 14,432 - Denominator: Shares used in computing net earnings per share of common stock, basic 39,301,620 2,812,684 Numerator: Net income 14,432 2,520 Dividends accumulated for the period - (2,520 ) Net income available to shareholders of common stock 14,432 - Denominator: Shares used in computing net earnings per share of common stock, diluted 44,455,964 2,812,684

GENERAL (Details)

GENERAL (Details) $ in Thousands, € in Millions	1 Months Ended	3 Months Ended		12 Months Ended
	Jul. 31, 2015USD ($)	Sep. 30, 2015USD ($)item	Sep. 30, 2014USD ($)	Jun. 30, 2015USD ($)	Sep. 30, 2015EUR (€)
General [Line Items]
Number of contract manufacturers | item		2
Number of vendors | item		2
Derivative financial instruments
Notional amount of derivative contract		$ 23,217			€ 6
Fair value of derivative liabilities current		41
Fair value of derivative assets current		342
Net derivative assets		301		$ 859
Loss from hedging transactions recorded in general and administrative expenses		1
Foreign exchange forward contracts		301		$ 859
Changes in unrealized gains (losses)		37
Reclassification adjustments for losses included in net income		1
Consideration paid for patents	$ 800	$ 800
Useful lives of patents		10 years
Amortization of intangible assets		$ 21
Trade payables [Member]
General [Line Items]
Concentration risk (as a percent)		71.00%		79.00%

GENERAL (Changes in Accumulated

GENERAL (Changes in Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Beginning balance	$ (222)
Other comprehensive income (loss) before reclassifications	(4)
Losses reclassified from accumulated other comprehensive income (loss)	1
Net current period other comprehensive income (loss)	(3)	$ (125)
Ending balance	$ (225)
Unrealized gains (losses) on cash flow hedges [Member]
Beginning balance
Other comprehensive income (loss) before reclassifications	$ 37
Losses reclassified from accumulated other comprehensive income (loss)	1
Net current period other comprehensive income (loss)	38
Ending balance	38
Unrealized gains (losses) on foreign currency translation [Member]
Beginning balance	(222)
Other comprehensive income (loss) before reclassifications	$ (41)
Losses reclassified from accumulated other comprehensive income (loss)
Net current period other comprehensive income (loss)	$ (41)
Ending balance	$ (263)

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
INVENTORIES [Abstract]
Raw materials	$ 16,870	$ 14,405
Finished goods	63,037	59,545
Inventories	$ 79,907	$ 73,950

WARRANTY OBLIGATIONS (Details)

WARRANTY OBLIGATIONS (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015
Changes in the Company's product warranty liability
Balance, at beginning of year	$ 31,879	$ 18,181
Additions and adjustments to cost of revenues	6,295	4,244
Usage and current warranty expenses	(2,270)	(1,143)
Balance, at end of year	35,904	21,282
Less current portion	(10,587)	(6,063)	$ (9,431)
Long term portion	$ 25,317	$ 15,219	$ 22,448

REVOLVING CREDIT LINE (Details)

REVOLVING CREDIT LINE (Details) - Revolving line of credit [Member] $ in Thousands	Feb. 17, 2015USD ($)
REVOLVING CREDIT LINE [Line Items]
Aggregate borrowings	$ 40,000
Maximum specified percentage of eligible trade receivables considered for determining maximum borrowing capacity	80.00%
Description of variable rate basis	Bank Lender's prime rate
Termination date	Dec. 31, 2016
Amount of liquidity need to maintain	$ 6,750
Minimum [Member]
REVOLVING CREDIT LINE [Line Items]
Applicable margin (as a percent)	0.50%
Maximum [Member]
REVOLVING CREDIT LINE [Line Items]
Applicable margin (as a percent)	2.00%

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - Derivative Financial Instruments, Assets [Member] - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015
FAIR VALUE MEASUREMENTS [Line Items]
Fair value of assets	$ 301	$ 859
Level 1 [Member]
FAIR VALUE MEASUREMENTS [Line Items]
Fair value of assets
Level 2 [Member]
FAIR VALUE MEASUREMENTS [Line Items]
Fair value of assets	$ 301	$ 859
Level 3 [Member]
FAIR VALUE MEASUREMENTS [Line Items]
Fair value of assets

LEASE INCENTIVE OBLIGATION (Det

LEASE INCENTIVE OBLIGATION (Details) $ in Thousands	Sep. 30, 2015USD ($)
LEASE INCENTIVE OBLIGATION[Abstract]
Operating lease receivable	$ 2,937
Received in cash from the Lessor	$ 2,875

COMMITMENTS AND CONTINGENT LI31

COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Future Minimum Lease Commitments) (Details) $ in Thousands	Sep. 30, 2015USD ($)
Future minimum lease commitments
2,016	$ 1,692
2,017	2,122
2,018	2,041
2,019	1,906
2020 and thereafter	8,319
Future minimum lease commitments amount	$ 16,080

COMMITMENTS AND CONTINGENT LI32

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Lease commitments, Guarantees, Royalty commitments, Governmental commitments, Contractual purchase obligations) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Lease commitments
Contract term	10 years
Rent expenses	$ 535	$ 315
Royalty commitments
Aggregate contingent liability to the BIRD-F amount	1,131
Governmental commitments
Governmental commitments amount	743
Contractual purchase obligations
Non-cancelable purchase obligations	72,781
Provision for contractual inventory purchase obligations	1,552
Office rent lease agreements [Member]
Guarantees [line Items]
Guarantees amount	780
Customs transactions [Member]
Guarantees [line Items]
Guarantees amount	51
Credit card limits [Member]
Guarantees [line Items]
Guarantees amount	$ 82

STOCK CAPITAL (Common Stock) (D

STOCK CAPITAL (Common Stock) (Details)	3 Months Ended
	Sep. 30, 2015$ / sharesshares	Jun. 30, 2015$ / sharesshares
STOCK CAPITAL [Abstract]
Reverse stock split ratio	0.33
Common stock capital
Par value | $ / shares	$ 0.0001	$ 0.0001
Authorized	125,000,000	125,000,000
Issued and outstanding	39,303,892	39,297,539

STOCK CAPITAL (Stock option pla

STOCK CAPITAL (Stock option plans) (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2014	Sep. 30, 2015
Option [Member]
Stock option plans
Number of options are available for future grant under the plan		379,358
Unrecognized compensation expense		$ 27,866
Option [Member] | 2015 Plan
Stock option plans
Number of options reserved for issuance under the plan		1,822,484
Percentage of common shares increase automatically in each year		5.00%
Option [Member] | Maximum [Member] | 2015 Plan
Stock option plans
Percentage of common shares increase automatically in each year	5.00%
Option [Member] | Employees and members of the board of directors [Member]
Stock option plans
Intrinsic value of options exercised		$ 107
Employee Stock Purchase Plan [Member]
Stock option plans
Number of options reserved for issuance under the plan		876,020
Options and RSUs [Member] | Employees and members of the board of directors [Member]
Stock option plans
Weighted average grant date fair values options granted to employees and executive directors		$ 25.09

STOCK CAPITAL (Summary of the a

STOCK CAPITAL (Summary of the activity in the share options and RSUs) (Details) - Employees and members of the board of directors [Member] - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Jun. 30, 2014
Option [Member]
Number of options
Granted	228,800
Weighted average exercise price
Granted	$ 25.09
Restricted Stock Units (RSUs) [Member]
Number of options
Granted	630,056
Weighted average exercise price
Granted
Options and RSUs [Member]
Number of options
Outstanding at the beginning of the period	6,102,222
Exercised	(3,923)
Forfeited or expired	(15,844)
Outstanding at the end of the period	6,941,311
Weighted average exercise price
Outstanding at the beginning of the period	$ 3.10
Exercised	2.62
Forfeited or expired	2.35
Outstanding at the end of the period	$ 3.55
Weighted average remaining contractual term in years
Outstanding	7 years 2 months 16 days	7 years 29 days
Aggregate intrinsic Value
Outstanding at the beginning of the period	$ 202,889
Outstanding at the end of the period	$ 134,964
Vested and expected to vest at the end of the period
Number of options	6,582,179
Weighted average exercise price	$ 3.51
Weighted average remaining contractual term in years	7 years 1 month 6 days
Aggregate intrinsic Value	$ 128,191
Exercisable at the end of the period
Number of options	3,793,798
Weighted average exercise price	$ 2.28
Weighted average remaining contractual term in years	5 years 7 months 17 days
Aggregate intrinsic Value	$ 78,326

STOCK CAPITAL (Schedule of exer

STOCK CAPITAL (Schedule of exercise price ranges) (Details) - Employees and members of the board of directors [Member]	3 Months Ended
	Sep. 30, 2015$ / sharesshares
Range of exercise price [Line Items]
Outstanding	6,941,311
Weighted average remaining contractual Life in years	7 years 2 months 16 days
Exercisable	3,793,798
Weighted average remaining contractual Life in years	5 years 7 months 17 days
$0.00 [Member]
Range of exercise price [Line Items]
Exercise price | $ / shares	$ 0
Outstanding	689,497
Weighted average remaining contractual Life in years	9 years 10 months 10 days
Exercisable
Weighted average remaining contractual Life in years
$0.50 - $1.50 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower | $ / shares	$ 0.50
Range of exercise price, upper | $ / shares	$ 1.50
Outstanding	1,244,156
Weighted average remaining contractual Life in years	3 years 5 months 5 days
Exercisable	1,244,156
Weighted average remaining contractual Life in years	3 years 5 months 5 days
$1.68 - $2.46 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower | $ / shares	$ 1.68
Range of exercise price, upper | $ / shares	$ 2.46
Outstanding	2,089,547
Weighted average remaining contractual Life in years	6 years 14 days
Exercisable	1,896,126
Weighted average remaining contractual Life in years	5 years 11 months 26 days
$3.03 - $3.96 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower | $ / shares	$ 3.03
Range of exercise price, upper | $ / shares	$ 3.96
Outstanding	661,501
Weighted average remaining contractual Life in years	8 years 3 months 14 days
Exercisable	291,659
Weighted average remaining contractual Life in years	8 years 2 months 26 days
$5.01 - $5.04 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower | $ / shares	$ 5.01
Range of exercise price, upper | $ / shares	$ 5.04
Outstanding	1,994,482
Weighted average remaining contractual Life in years	9 years 2 months 1 day
Exercisable	361,857
Weighted average remaining contractual Life in years	9 years 1 month 24 days
$9.36 [Member]
Range of exercise price [Line Items]
Exercise price | $ / shares	$ 9.36
Outstanding	33,328
Weighted average remaining contractual Life in years	9 years 4 months 2 days
Exercisable
Weighted average remaining contractual Life in years
$25.09 [Member]
Range of exercise price [Line Items]
Exercise price | $ / shares	$ 25.09
Outstanding	228,800
Weighted average remaining contractual Life in years	9 years 10 months 20 days
Exercisable
Weighted average remaining contractual Life in years

STOCK CAPITAL (Options and RSUs

STOCK CAPITAL (Options and RSUs issued to non-employee consultants) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Stock option plans
Stock compensation expenses	$ 1,832	$ 320
Non-employee consultants
Stock option plans
Stock compensation expenses	$ 119	$ 23
Options and RSUs [Member] | Non-employee consultants
Stock option plans
Outstanding at the end of the period	138,328
Exercisable at the end of the period	88,045
Options and RSUs [Member] | Non-employee consultants | July 31, 2008 [Member]
Stock option plans
Outstanding at the end of the period	33,333
Exercise price	$ 0.87
Exercisable at the end of the period	33,333
Options and RSUs [Member] | Non-employee consultants | January 26, 2011 [Member]
Stock option plans
Outstanding at the end of the period	5,000
Exercise price	$ 2.01
Exercisable at the end of the period	5,000
Options and RSUs [Member] | Non-employee consultants | January 26, 2012 [Member]
Stock option plans
Outstanding at the end of the period	33,333
Exercise price	$ 2.46
Exercisable at the end of the period	33,333
Options and RSUs [Member] | Non-employee consultants | October 24, 2012 [Member]
Stock option plans
Outstanding at the end of the period	6,666
Exercise price	$ 2.46
Exercisable at the end of the period	5,000
Options and RSUs [Member] | Non-employee consultants | January 23, 2013 [Member]
Stock option plans
Outstanding at the end of the period	3,333
Exercise price	$ 3.03
Exercisable at the end of the period	2,361
Options and RSUs [Member] | Non-employee consultants | January 27, 2014 [Member]
Stock option plans
Outstanding at the end of the period	4,998
Exercise price	$ 3.51
Exercisable at the end of the period	1,943
Options and RSUs [Member] | Non-employee consultants | May 1, 2014 [Member]
Stock option plans
Outstanding at the end of the period	6,000
Exercise price	$ 3.51
Exercisable at the end of the period	2,417
Options and RSUs [Member] | Non-employee consultants | September 17, 2014 [Member]
Stock option plans
Outstanding at the end of the period	10,830
Exercise price	$ 3.96
Exercisable at the end of the period	3,436
Options and RSUs [Member] | Non-employee consultants | October 29, 2014 [Member]
Stock option plans
Outstanding at the end of the period	6,668
Exercise price	$ 5.01
Exercisable at the end of the period	1,222
Options and RSUs [Member] | Non-employee consultants | August 19, 2015 [Member]
Stock option plans
Outstanding at the end of the period	28,167
Exercise price	$ 0
Exercisable at the end of the period

STOCK CAPITAL (Schedule of stoc

STOCK CAPITAL (Schedule of stock-based compensation expense for employees and consultants) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Stock-based compensation expenses
Total stock-based compensation expense	$ 1,832	$ 320
Cost of revenues [Member]
Stock-based compensation expenses
Total stock-based compensation expense	180	37
Research and development [Member]
Stock-based compensation expenses
Total stock-based compensation expense	395	110
Selling and marketing [Member]
Stock-based compensation expenses
Total stock-based compensation expense	616	102
General and administrative [Member]
Stock-based compensation expenses
Total stock-based compensation expense	$ 641	$ 71

BASIC AND DILUTED NET EARNING39

BASIC AND DILUTED NET EARNINGS PER SHARE (Narrative) (Details) - shares	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
BASIC AND DILUTED NET EARNINGS PER SHARE [Abstract]
Total weighted average number of shares related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock and common stock, excluded from the calculation of diluted net earnings (loss) per share due to their anti-dilutive effect	0	1,552,809

BASIC AND DILUTED NET EARNING40

BASIC AND DILUTED NET EARNINGS PER SHARE (Schedule of Computation of Basic and Diluted Net Earnings (Loss) Per Share) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Numerator:
Net income (loss)	$ 14,432	$ 2,520
Dividends accumulated for the period
Net income (loss) available to shareholders of common stock	$ 14,432
Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic (in shares)	39,301,620	2,812,684
Numerator:
Net income (loss)	$ 14,432	$ 2,520
Dividends accumulated for the period
Net income (loss) available to shareholders of common stock	$ 14,432
Denominator:
Shares used in computing net earnings (loss) per share of common stock, diluted (in shares)	44,455,964	2,812,684

CONCENTRATION OF CREDIT RISK 41

CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS (Details)	3 Months Ended	12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015
Revenues [Member] | Customer one [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	25.80%	24.60%
Revenues [Member] | Customer two [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	25.80%
Accounts receivable [Member] | Customer one [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	49.50%	30.00%
Accounts receivable [Member] | Customer two [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	49.50%	30.00%
Accounts receivable [Member] | Customer three [Member]
Concentration Risk [Line Items]
Concentration risk (as a percent)	49.50%